Trustmark National Bank Trust Department’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,724
Closed -$205K 303
2024
Q3
$205K Buy
1,724
+14
+0.8% +$1.87K 0.02% 289
2024
Q2
$244K Buy
+1,710
New +$227K 0.02% 266

Other funds holding NVO

Trustmark National Bank Trust Department's NVO Position: Q4 2024 in Review

Trustmark National Bank Trust Department sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,724 shares — an estimated $205K sold.

Trustmark National Bank Trust Department first reported a position in NVO in Q2 2024 and held it in 2 quarters. The position peaked at $244K in Q2 2024. 1,664 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Trustmark National Bank Trust Department reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 1,724 Novo Nordisk shares in Q4 2024, an estimated $205K.
  • Trustmark National Bank Trust Department first reported a position in Novo Nordisk in Q2 2024 and held it in 2 quarters.
  • Trustmark National Bank Trust Department's Novo Nordisk position peaked at $244K in Q2 2024.
  • 1,664 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Trustmark National Bank Trust Department's 13F filing for Q4 2024, filed 13 Feb 2025.